Provide immunologic rationale for JAK directed therapy in rheumatic disease

Join Claudia Rivera Salas, NP from East Lansing, MI, discusses the immunologic rationale for JAK-STAT therapy in rheumatic diseases in this FAQ video module. She explains the discovery of protein kinases, the role of phosphorylation in cell communication, and how JAK-STAT pathways are implicated in autoimmune conditions like rheumatoid arthritis, psoriasis, and Crohn’s disease. Understanding these pathways helps providers in dermatology, gastroenterology, and rheumatology develop effective treatment strategies.